Prognostic value of RRM1 and its effect on chemoresistance in pancreatic cancer.

Lin, Xingyi; Tan, Ying; Pan, Lele; Tian, Zhenfeng; Lin, Lijun; Su, Mingxin; Ou, Guangsheng; Chen, Yinting

Lin, Xingyi; Tan, Ying; Pan, Lele; Tian, Zhenfeng; Lin, Lijun; Su, Mingxin; Ou, Guangsheng; Chen, Yinting.

Afiliação

Lin X; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
Tan Y; Department of Gastroenterology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
Pan L; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
Tian Z; Department of Gastroenterology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
Lin L; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
Su M; Department of Gastroenterology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
Ou G; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
Chen Y; Department of Gastroenterology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.

Cancer Chemother Pharmacol ; 93(3): 237-251, 2024 03.

Article em En | MEDLINE | ID: mdl-38040978

Assuntos

Gencitabina; Neoplasias Pancreáticas; Humanos; Desoxicitidina/farmacologia; Desoxicitidina/uso terapêutico; Prognóstico; Antimetabólitos Antineoplásicos/uso terapêutico; Resistencia a Medicamentos Antineoplásicos; Neoplasias Pancreáticas/tratamento farmacológico; Neoplasias Pancreáticas/genética; Neoplasias Pancreáticas/metabolismo; Ribonucleosídeo Difosfato Redutase

Palavras-chave

Bioinformatics; Gemcitabine resistance; Immune infiltration; Nomogram; Pancreatic cancer; RRM1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Gencitabina Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Gencitabina Idioma: En Ano de publicação: 2024 Tipo de documento: Article